Aaron Royston
CIK 1727703 · last filed 2023-04-26
Aaron Royston is a corporate insider who has filed 6 SEC Form 4 insider transactions across 3 companies since 2019. The most recent filing, for VTYX, was dated Apr 26, 2023. Across all open-market trades the lifetime net is +$9.0M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
6
$9.00M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ventyx Biosciences, Inc. (VTYX) Delisted | Director | 3,684,769 | $13.99 | $51.55M | $5.00M | 3 | 2023-04-26 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Director | — | — | — | $0 | 2 | 2019-08-08 |
| Akero Therapeutics, Inc. (AKRO) Delisted | Director | 3,954,858 | $54.65 | $216.13M | $4.00M | 1 | 2019-06-25 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-26 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-25 | Ventyx Biosciences, Inc. (VTYX) Delisted | Mixed | +3,997,269 | $5.00M | EDGAR |
| 2019-08-08 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-27 | VYNE Therapeutics Inc. (MNLO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-25 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | +3,954,858 | $4.00M | EDGAR |